| Literature DB >> 32676065 |
Antonio Real-Hohn1, Martin Groznica1, Nadine Löffler1, Dieter Blaas1, Heinrich Kowalski1.
Abstract
Thermal shift assays measure the stability of macromolecules and macromolecular assemblies as a function of temperature. The Particle Stability Thermal Release Assay (PaSTRy) of picornaviruses is based on probes becoming strongly fluorescent upon binding to hydrophobic patches of the protein capsid (e.g., SYPRO Orange) or to the viral RNA genome (e.g., SYTO-82) that become exposed upon heating virus particles. PaSTRy has been exploited for studying the stability of viral mutants, viral uncoating, and the effect of capsid-stabilizing compounds. While the results were usually robust, the thermal shift assay with SYPRO Orange is sensitive to surfactants and EDTA and failed at least to correctly report the effect of excipients on an inactivated poliovirus 3 vaccine. Furthermore, interactions between the probe and capsid-binding antivirals as well as mutual competition for binding sites cannot be excluded. To overcome these caveats, we assessed differential scanning fluorimetry with a nanoDSF device as a label-free alternative. NanoDSF monitors the changes in the intrinsic tryptophan fluorescence (ITF) resulting from alterations of the 3D-structure of proteins as a function of the temperature. Using rhinovirus A2 as a model, we demonstrate that nanoDFS is well suited for recording the temperature-dependence of conformational changes associated with viral uncoating with minute amounts of sample. We compare it with orthogonal methods and correlate the increase in viral RNA exposure with PaSTRy measurements. Importantly, nanoDSF correctly identified the thermal stabilization of RV-A2 by pleconaril, a prototypic pocket-binding antiviral compound. NanoDFS is thus a label-free, high throughput-customizable, attractive alternative for the discovery of capsid-binding compounds impacting on viral stability.Entities:
Keywords: capsid binders; intrinsic tryptophan fluorescence; picornaviruses; pleconaril; rhinovirus; uncoating
Year: 2020 PMID: 32676065 PMCID: PMC7333345 DOI: 10.3389/fmicb.2020.01442
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 2RV-A2 nanoDSF and PaSTRy analysis and correlation with negative stain ultrastructure analysis. (A) RV-A2 in PBS (1 mg/ml) was analyzed by nanoDSF by heating from 25 to 95°C with a ramp rate of 1°C/min. Samples were excited at 280 nm, and the intensity of the TRP emission at 330 and 350 nm was recorded for every ∼0.02°C temperature increase. In the PaSTRy assay, the virus preparation (0.5 mg/ml) was heated in a real-time PCR machine from 25 to 95°C at a 1.5°C/min ramp rate. Samples were excited at 541 nm, and the emission intensity was determined at 560 nm at each 0.5°C temperature increase. The obtained data were plotted against the temperature, with the left Y-axis indicating the TRP fluorescence emission ratio as the intensity at 350 nm/intensity at 330 nm (curve is shown in orange) and the right Y-axis the normalized SYTO-82 emission intensity at 560 nm (curve is shown in green). (B) First derivatives calculated from the experimental data shown in panel (A). All curves (in panels A,B) were normalized to their individual minimum and maximum values using GraphPad Prism 6.01 for better comparison and represent the mean of 3 independent thermal scans; only the temperature range relevant for the heat-triggered virus uncoating is shown. TA is the temperature where 50% of N into A particle conversion takes place, TB corresponds to 50% conversion of (full) A into empty B particles. (C) RV-A2 in PBS was subject to the same thermal gradient as in the nanoDSF analysis, using a real-time PCR machine instead. The heating was terminated at 52 and 55°C, and the samples were quickly placed on ice followed by particle imaging via negative stain transmission electron microscopy. A, B and remaining N particles were counted and identified based on their differential dye penetrability. The percentage of (sub)viral particles in each class is presented as a bar graph for each temperature, normalized to the total number of native particles before heating. In total, ten distinct fields were evaluated, and the mean and standard deviation calculated. (D) Representative micrographs at a magnification of 110 kx (B particles are indicated with white arrows). (E) Graphs of the 350 and 330 nm TRP emission of heated RV-A2 as used for the ITF ratio calculation in panel (A). Dotted straight lines represent the pretransition baseline obtained by data fitting in each instance. The temperature window encompassing the TRP red-shift as a consequence of the N into A particle conversion is highlighted in green. For both curves (blue, red) a drastic sigmoid increase in TRP intensity is visible thereafter (from about 55 to 60°C), which is not evident in a distinct red-shift and thus the Em350nm/Em330nm ratio. Notably, the onset of the sigmoid part in both instances (E330 and E350) practically coincides with the peak of the SYTO-82 signal (55°C) in panel (A). (F) Graphs of the first derivative of the data in panel (E). TB, which is identical for both maxima, corresponds to the temperature where 50% of A particles transformed into B particles. The N into A conversion identified by the increase in red-shift is not visible as a discrete maximum in this plot. (E) Purified RV-A2 was heated at 56°C for 10 min resulting in the formation of mostly B particles, which were then analyzed by nanoDSF identically as outlined in panel (A) for the native virus. In the obtained raw 350 and 330 nm emission curves, a slight sigmoidal transition is evident from 57 to 60°C. As expected, the maximum at 60°C coincides with the maximum for the A into B particle conversion. Dotted straight lines represent the respective pretransition baselines obtained by data fitting.
FIGURE 1Positions of RV-A2 tryptophan residues within a biological protomer and fluorescence spectra of RV-A2. (A) Left: 3D-structure surface-view (pdb:1FPN) with one protomer highlighted with a dashed black line. The solvent accessible surface is rendered by using a rolling sphere of 1.4 Å radius in Chimera. Middle and right: Surface of an isolated protomer viewed from within and from without the capsid. VP1, VP2, VP3, and VP4 are colored gray, blue, green, and rose, respectively. Tryptophan residues are depicted in red; the locations of TRP2038 and TRP3027 are additionally highlighted in the boxed ribbon diagrams representing the respective local tertiary structure. (B) Fluorescence spectra of RV-A2 in PBS. Normalized excitation (250–300 nm) and emission (300 – 400 nm) spectra were recorded in 1 nm steps. The measurement was repeated eight times, and the mean is shown. A.U., arbitrary units.
FIGURE 3nanoDSF demonstrates the thermostabilization of RV-A2 by pleconaril. Purified RV-A2 was diluted in PBS (1 mg/ml) ± 1 mM pleconaril (Plec.) and analyzed by nanoDSF. The heating rate was 1°C/min and tryptophan fluorescence was recorded in steps of ∼0.02°C. (A) Ratio Em350nm/Em330nm plotted against the temperature. The steeper sigmoidal curve in the presence of pleconaril relates to the faster transition of native (N) to A particles at a higher temperature after the drug has been thermally expelled from the pocket. Orange trace, untreated virus; brown trace, DMSO treated virus (solvent control “+DMSO”); purple trace, pleconaril treated virus (“+Plec”). (B) The first derivative of the curves in panel (A). The temperature where 50% of the virus has converted into A particles is indicated, which is shifted by ∼5°C to the right in the presence of the capsid-stabilizing compound. The curves represent the mean of three independent measurements. (C) Raw 350 and 330 nm emission curves of purified RV-A2 treated with pleconaril used for ITF Ratio calculation in panel (A). Dotted straight lines represent the pretransition baseline obtained by data fitting. The overall profile is similar to Figure 2C, though the onset of A into B particle conversion (the left minimum of the Em330nm and Em350nm curves) is shifted by about 5°C to higher temperatures.